Skip to main navigation Skip to search Skip to main content

Subtherapeutic anti-Xa levels in a patient with cirrhosis receiving low molecular weight heparin for deep vein thromboses

Research output: Contribution to conferencePoster

Original languageAmerican English
StatePublished - Dec 1 2016

Disciplines

  • Pharmacy and Pharmaceutical Sciences

Cite this